Tim Lefever is the Director of Discovery at Nalu Bio. He is an experienced Director with a demonstrated history of 20+ years of preclinical in vivo research and leading effective teams at organizations such as Canopy Growth and Research Triangle Institute. He has authored or co-authored numerous manuscripts and presented research findings at a variety of scientific conferences over the past 20 years.
At CannMed 24, Tim will present “Characterization of Less Studied Cannabis Phytochemicals” which investigates the pharmacological, physicochemical, and basic toxicological characteristics of cannabis phytochemicals. During our conversation, we discuss:

How Tim and his team choose which phytochemicals to study
What makes the varin cannabinoids particularly interesting
The difference between chemically derived compounds vs plant-derived compounds
Which phytochemicals show the most promise
Modifying phytochemicals to improve their effectiveness

Thanks to This Episode’s Sponsor: Brains Bioceutical
Brains Bioceutical is a global leader in EU-GMP-certified production of naturally-sourced active pharmaceutical ingredients for the pharmaceutical and nutraceutical industries. With a unique suite of licences, Brains Bioceutical is one of the only natural plant-based phytochemical API manufacturers in commercial production today, and is involved in academic and clinical trials across the globe. Learn more at brainsbioceutical.com
Additional Resources

nalubio.com
Register for CannMed 24
What Makes CannMed Unique and Why You Don’t Want to Miss It
Review the Podcast!
CannMed Archive

Ver todos los episodios